Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
8.46T | 8.50T | 8.38T | 7.39T | 6.70T | Gross Profit |
2.63T | 2.34T | 2.26T | 2.08T | 1.97T | EBIT |
467.22B | 360.96B | 288.57B | 357.53B | 258.60B | EBITDA |
900.79B | 845.50B | 718.31B | 731.06B | 615.19B | Net Income Common Stockholders |
366.20B | 443.99B | 265.50B | 255.33B | 165.08B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
847.56B | 1.35T | 989.16B | 1.42T | 1.74T | Total Assets |
9.34T | 9.41T | 8.06T | 8.02T | 6.85T | Total Debt |
1.57T | 1.63T | 1.46T | 1.90T | 1.45T | Net Debt |
720.68B | 506.65B | 637.61B | 691.41B | -145.80B | Total Liabilities |
4.47T | 4.69T | 4.27T | 4.68T | 4.08T | Stockholders Equity |
4.69T | 4.54T | 3.62T | 3.16T | 2.59T |
Cash Flow | Free Cash Flow | |||
23.75B | 219.70B | 150.86B | -45.15B | 207.61B | Operating Cash Flow |
796.08B | 866.90B | 520.74B | 252.63B | 504.04B | Investing Cash Flow |
-859.93B | -578.84B | -344.03B | -796.15B | 176.60B | Financing Cash Flow |
-190.35B | -83.49B | -607.01B | 58.91B | -177.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $22.89T | 19.86 | 14.32% | 0.53% | -0.49% | 19.71% | |
73 Outperform | ¥169.98B | 8.34 | 16.78% | 1.77% | 3.02% | 60.53% | |
72 Outperform | ¥3.59T | 9.80 | 7.85% | 2.60% | -0.45% | -17.53% | |
64 Neutral | $2.42T | 100.46 | 0.71% | 3.19% | 0.51% | -76.08% | |
63 Neutral | $246.31B | 30.70 | 3.45% | 0.03% | -2.63% | -31.26% | |
62 Neutral | $11.92B | 10.48 | -7.50% | 2.95% | 7.40% | -8.18% | |
53 Neutral | ¥442.53B | 12.18 | ― | -6.97% | ― |